Muscular Dystrophy Therapy Based On Tarantula-Venom To Be Advanced By UB Scientists’ Biotech Company

University at Buffalo biophysicists have found a protein in tarantula venom that shows promise as a potential therapy for muscular dystrophy (MD). They have formed a start-up biotech company in Buffalo -- Rose Pharmaceuticals -- to advance the drug to clinical trials...
This entry was posted in News from Other Sources. Bookmark the permalink. Both comments and trackbacks are currently closed.